APA (7th ed.) Citation

Yan, J., Shi, L., Lin, S., & Li, Y. (2021). MicroRNA-624-mediated ARRDC3/YAP/HIF1α axis enhances esophageal squamous cell carcinoma cell resistance to cisplatin and paclitaxel. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Yan, Jie, Litong Shi, Shan Lin, and Yi Li. MicroRNA-624-mediated ARRDC3/YAP/HIF1α Axis Enhances Esophageal Squamous Cell Carcinoma Cell Resistance to Cisplatin and Paclitaxel. Taylor & Francis Group, 2021.

MLA (8th ed.) Citation

Yan, Jie, et al. MicroRNA-624-mediated ARRDC3/YAP/HIF1α Axis Enhances Esophageal Squamous Cell Carcinoma Cell Resistance to Cisplatin and Paclitaxel. Taylor & Francis Group, 2021.